Clinical ResearchPhase II Study of Risk-Adapted Therapy of Newly Diagnosed, Aggressive Non-Hodgkin Lymphoma Based on Midtreatment FDG-PET Scanning
Under a Creative Commons license
open archive
Key Words
Lymphoma
Positron emission tomography (PET)
Prognosis
Autologous stem cell transplantation
Cited by (0)
Financial disclosure: See Acknowledgments on page 247.
Copyright © 2009 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.